
Alghad
HealthJordan22 Nov 2026, 12:43
A Blood Marker Detects Ovarian Cancer in Microscopic Stages
Machine translated | Original title: مؤشر في الدم يرصد سرطان المبيض في مراحله المجهرية
The short version
Scientific research indicated the possibility of detecting ovarian cancer at earlier stages via a molecular marker in the blood. This could pave the way for discovering the disease before it becomes invasive.
The full story
Medical professionals face significant challenges in detecting ovarian cancer during its earliest phases, as current diagnostic methods rely on ultrasounds and protein blood tests that can sometimes register elevated levels for non-cancerous reasons. Addressing this difficulty, a research team featuring cancer biologists Rajan Gogna and Isha Madan identified a potential blood biomarker involving a ribonucleic acid known as "Tu-stroma" found within blood serum. A study involving five hundred and six women revealed that patients with early-stage ovarian cancer and related precursors exhibited high levels of this RNA, which originates from early cancer cells.
Despite these findings, the researchers emphasized that extensive validation across broader samples remains necessary before clinical implementation, especially since false positives occurred among healthy individuals and patients with other conditions. The study authors cautioned against altering current preventative protocols based solely on these preliminary insights. Ultimately, the scientific team aims to utilize these molecular discoveries to halt micro-lesions before they advance, potentially replacing preventative surgeries currently determined primarily by genetic risk levels.
Source: Alghad
Read the full story at the sourceAsk Fahim about this story
Fahim answers from this story and, when it is not there, searches the web and keeps that part separate. No opinions.
Automated answers from the story text; they can be wrong. Check the source.




Comments
Comments are checked automatically. No abuse, links or phone numbers.